NATIONAL ORGANIZATION FOR RARE DISORDERS INC

EIN: 133223946 501(c)(3)

NORWELL, MA

Total Revenue
$34,577,196
Total Expenses
$40,401,111
Total Assets
$66,900,297
Net Assets
$63,632,089
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
1983
Legal Domicile
NY
Principal Officer
NEETA KOTECHA
Phone
6172497300
Tax Period
2025-01-01 to 2025-12-31

NATIONAL ORGANIZATION FOR RARE DISORDERS INC, founded in 1983, is a mid-sized nonprofit that reported $34.6M in total revenue in fiscal year 2025. Revenue fell 32% from the prior year — a significant decline worth monitoring. Expenses of $40.4M exceeded revenue, resulting in a 17% operating deficit.

Mission

NORD STRIVES TO IMPROVE THE HEALTH AND WELL-BEING OF PEOPLE WITH RARE DISEASES BY DRIVING ADVANCES IN CARE, RESEARCH, AND POLICY.

Program Service Accomplishments

Program 1
Expenses: $25,200,680 Revenue: $4,936,057

NORD'S PATIENT ASSISTANCE PROGRAMS PROVIDE ELIGIBLE INDIVIDUALS WITH FINANCIAL ASSISTANCE TO SUPPORT THE BROAD RANGE OF CARE AND TREATMENT NEEDS ASSOCIATED WITH MANAGING A RARE DISEASE. EACH...

Read more

NORD'S PATIENT ASSISTANCE PROGRAMS PROVIDE ELIGIBLE INDIVIDUALS WITH FINANCIAL ASSISTANCE TO SUPPORT THE BROAD RANGE OF CARE AND TREATMENT NEEDS ASSOCIATED WITH MANAGING A RARE DISEASE. EACH DISEASE-SPECIFIC PROGRAM IS DESIGNED TO ADDRESS THE NUANCES OF THE INDIVIDUAL CONDITION AND THE UNIQUE NEEDS OF ITS PATIENT COMMUNITY. ASSISTANCE MAY INCLUDE SUPPORT FOR HEALTH INSURANCE PREMIUMS, COPAYMENTS, AND COINSURANCE, AS WELL AS CERTAIN COVERED OUT-OF-POCKET MEDICAL EXPENSES. NORD'S APPROACH ENSURES THAT ELIGIBLE INDIVIDUALS, WHETHER COMMERCIALLY INSURED, PUBLICLY INSURED, UNDERINSURED, OR UNINSURED, RECEIVE THE FINANCIAL SUPPORT NECESSARY TO ACCESS THE CARE AND TREATMENT PRESCRIBED BY THEIR HEALTH CARE PROVIDER(S). IN 2025, NORD'S PATIENT ASSISTANCE PROGRAMS PROVIDED FINANCIAL ASSISTANCE TO 6,880 INDIVIDUALS, INCLUDING 6,602 INDIVIDUALS SUPPORTED THROUGH OUR PAP AND 278 INDIVIDUALS WHO RECEIVED TRAVEL AND LODGING ASSISTANCE TO PARTICIPATE IN CLINICAL TRIALS.

Program 2
Expenses: $1,921,195 Revenue: $2,046,711

NORD'S EDUCATIONAL INITIATIVES STRIVE TO EMPOWER PATIENTS AND THEIR FAMILIES, INFORM AND EDUCATE STUDENTS ACROSS DISCIPLINES FROM HIGH SCHOOL THROUGH GRADUATE SCHOOL, AND SUPPORT THE VITALLY...

Read more

NORD'S EDUCATIONAL INITIATIVES STRIVE TO EMPOWER PATIENTS AND THEIR FAMILIES, INFORM AND EDUCATE STUDENTS ACROSS DISCIPLINES FROM HIGH SCHOOL THROUGH GRADUATE SCHOOL, AND SUPPORT THE VITALLY IMPORTANT WORK OF PHYSICIANS AND OTHER HEALTHCARE PROFESSIONALS IN IMPROVING THE RECOGNITION OF SYMPTOMS OF RARE DISEASE AND EARLY, ACCURATE DIAGNOSIS AS WELL AS IMPROVING CLINICIAN KNOWLEDGE AND COMPETENCE IN TREATING RARE DISEASES. THIS IS DONE THROUGH THE DEVELOPMENT OF NORD'S RARE DISEASE DATABASE OF MORE THAN 1,480 COMPREHENSIVE EXPERT-WRITTEN REPORTS ON SPECIFIC RARE DISORDERS, THE DELIVERY OF RARE DISEASE VIDEOS AND WEBINARS, AND THROUGH ROBUST EDUCATIONAL PROGRAMMING WITH NORD'S CME PROGRAM AND AT THE NORD RARE DISEASES AND ORPHAN PRODUCTS BREAKTHROUGH SUMMIT. IN 2025, 759 PEOPLE ATTENDED THE NORD SUMMIT IN PERSON, AND 60 PEOPLE REGISTERED TO ATTEND VIRTUALLY. ALSO, IN 2025, THERE WERE OVER 15 MILLION VISITORS TO NORD'S RARE DISEASE DATABASE.

Program 3
Expenses: $3,000,676 Revenue: $952,549

IN 2025, NORD CONTINUED TO ADVANCE THE IAMRARE NATURAL HISTORY AND REGISTRY PLATFORM TO STRENGTHEN RARE DISEASE RESEARCH AND IMPROVE THE PATIENT EXPERIENCE IN SUPPORT OF THERAPEUTIC DEVELOPMENT...

Read more

IN 2025, NORD CONTINUED TO ADVANCE THE IAMRARE NATURAL HISTORY AND REGISTRY PLATFORM TO STRENGTHEN RARE DISEASE RESEARCH AND IMPROVE THE PATIENT EXPERIENCE IN SUPPORT OF THERAPEUTIC DEVELOPMENT. MAJOR PLATFORM ENHANCEMENTS INCLUDED THE LAUNCH OF A REDESIGNED UI TO STREAMLINE NAVIGATION AND IMPROVE CROSS-BROWSER CONSISTENCY, AND THE RELEASE OF THE IAMRARE MOBILE APP WITH FEATURES SUCH AS PUSH NOTIFICATIONS FOR SURVEY REMINDERS AND DEVICE-LEVEL ACCESSIBILITY CONTROLS. AS OF DECEMBER 2025, THERE WERE 22,142 CONSENTED PARTICIPANTS ACROSS 51 REGISTRIES. IN ADDITION, DURING 2025, 10 NEW RARE DISEASE REGISTRIES WERE LAUNCHED, REPRESENTING THE LARGEST NUMBER INITIATED IN A SINGLE YEAR, AND THE RESEARCH TEAM WAS SUPPORTING THE DEVELOPMENT OF 24 ADDITIONAL REGISTRIES.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2025)

Revenue Breakdown

Contributions & Grants $23,944,805
Program Service Revenue $7,935,317
Investment Income $2,697,074
Other Revenue $0
TOTAL REVENUE $34,577,196

Expense Breakdown

Grants Paid $22,081,890
Salaries & Benefits $12,244,648
Fundraising Expenses $3,705,242
Program Expenses $32,777,209
Other Expenses $6,074,573
TOTAL EXPENSES $40,401,111

Year-over-Year Comparison

2025 2024 Change
Revenue $34,577,196 $50,676,798 -0.3%
Expenses $40,401,111 $43,034,462 -0.1%
Net Income $-5,823,915 $7,642,336 -1.8%
Key Indicators
Grants to Organizations Grants to Individuals Lobbying Political Activity Foreign Activities Donor Advised Fund Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
16
Independent Members
15
Employees
116
Volunteers
1308

Governance Policies

Conflict of Interest Policy
Whistleblower Policy
Document Retention Policy

Special Practices & Reported Activities

Operated a School
Operated a Hospital
Provided First Class Travel
Reported Conflict of Interest
Reported Asset Diversion
Excess Benefit Transaction
Made Political Expenditures
Engaged in Lobbying
Operated Donor Advised Fund
Maintained Art Collections
Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
8
$1,110,324
Total Directors
16
$512,049
Key Employees
0
$0
Highest Compensated
5
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
PAMELA GAVIN CEO 35.00
Officer Director
$479,961 $32,088 $512,049
KATHLEEN HOLCOMBE CHAIR 10.00
Officer Director
$0 $0 $0
DENNIS JACKMAN VICE CHAIR 5.00
Officer Director
$0 $0 $0
MARK SKINNER TREASURER 5.00
Officer Director
$0 $0 $0
LORNA WEIR SECRETARY 5.00
Officer Director
$0 $0 $0
KIM ISENBERG DIRECTOR 1.00
Director
$0 $0 $0
PAUL LYONS DIRECTOR 1.00
Director
$0 $0 $0
SUSAN BERRY MD DIRECTOR 1.00
Director
$0 $0 $0
SHAFALI JESTE MD DIRECTOR (UNTIL 12/2025) 1.00
Director
$0 $0 $0
PHILIP PEARL MD DIRECTOR (UNTIL 12/2025) 1.00
Director
$0 $0 $0
MIKE PORATH DIRECTOR 1.00
Director
$0 $0 $0
TOM KELLY DIRECTOR 1.00
Director
$0 $0 $0
STEVEN MAH PHD DIRECTOR 1.00
Director
$0 $0 $0
ALAN MILLER MD PHD DIRECTOR 1.00
Director
$0 $0 $0
SHELDON SCHUSTER PHD DIRECTOR 1.00
Director
$0 $0 $0
JIM PALMA DIRECTOR (UNTIL 12/2025) 1.00
Director
$0 $0 $0
PETER SALTONSTALL SENIOR ADVISOR & CEO EMERITUS 17.00
Officer
$47,303 $2,358 $49,661
NEETA KOTECHA VP & CFO 35.00
Officer
$186,375 $38,387 $224,762
KELLEEN ESPERIAS CHIEF STRATEGY & OPERATIONS OFFICER 35.00
Officer
$294,239 $29,613 $323,852
EDWARD NEILAN CHIEF MEDICAL & SCIENTIFIC OFFICER 35.00
Highest
$270,662 $60,560 $331,222
PRASHANT GOEL VP INFORMATION TECHNOLOGY 35.00
Highest
$293,256 $15,368 $308,624
TRACEY SIKORA VP OF RESEARCH & CLINICAL PROGRAMS 35.00
Highest
$194,233 $24,588 $218,821
ALEXANDRA MOORE VP OF DEVELOPMENT 35.00
Highest
$254,340 $12,713 $267,053
JILL POLLANDER VP PATIENT SERVICES 35.00
Highest
$187,802 $24,142 $211,944
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2025 $34,577,196 $40,401,111 $66,900,297 $-5,823,915
2024 $50,676,798 $43,034,462 $72,321,740 $7,642,336
2023 $66,397,453 $52,832,739 $65,154,464 $13,564,714
2022 $59,872,383 $48,420,739 $49,542,120 $11,451,644
2021 $43,188,172 $57,720,517 $37,875,246 $-14,532,345
2020 $42,843,360 $52,712,119 $52,774,540 $-9,868,759
2019 $52,413,377 $41,789,694 $61,751,096 $10,623,683
2018 $47,123,099 $34,074,818 $50,838,028 $13,048,281
Explore More Nonprofits
Top 100 Nonprofits in Massachusetts Largest U.S. Nonprofits Best Rated Nonprofits Most Efficient Nonprofits

Compare NATIONAL ORGANIZATION FOR RARE DISORDERS INC with other nonprofits in Massachusetts and across the country.